Review
doi: 10.1016/s0361-9230(01)00772-9.
Stem cells in the treatment of Parkinson's disease
Affiliations
- PMID: 12031276
- DOI: 10.1016/s0361-9230(01)00772-9
Item in Clipboard
Review
Stem cells in the treatment of Parkinson's disease
Brain Res Bull.
2002 Apr.
Abstract
Stem cells have been suggested as candidate therapeutic tools for neurodegenerative disorders, given their ability to give rise to the appropriate cell types after grafting in vivo. In this review I summarize some of the evidence currently available concerning two approaches for the treatment of Parkinson's disease: (1) The generation of dopaminergic neurons from embryonic stem cells, multipotent stem cells, and neuronal progenitor cells for cell replacement therapy. (2) The engineering of multipotent stem cells to release glial cell-line derived neurotrophic factor, a potent neurotrophic factor for dopaminergic neurons, in a neuroprotective and neuroregenerative approach to the treatment of Parkinson's disease.
Similar articles
-
Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures.Neuroscience. 2001;108(2):273-84. doi: 10.1016/s0306-4522(01)00418-3. Neuroscience. 2001. PMID: 11734360
-
Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.J Comp Neurol. 2002 Jan 21;442(4):320-30. doi: 10.1002/cne.10108. J Comp Neurol. 2002. PMID: 11793337
-
Models of repair mechanisms for future treatment modalities of Parkinson's disease.Brain Res Bull. 2002 Apr;57(6):839-46. doi: 10.1016/s0361-9230(01)00773-0. Brain Res Bull. 2002. PMID: 12031282 Review.
-
GDNF promotes neuronal differentiation and dopaminergic development of mouse mesencephalic neurospheres.Neurosci Lett. 2004 May 6;361(1-3):52-5. doi: 10.1016/j.neulet.2003.12.106. Neurosci Lett. 2004. PMID: 15135891
-
Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.Prog Brain Res. 2002;138:411-20. doi: 10.1016/S0079-6123(02)38090-7. Prog Brain Res. 2002. PMID: 12432781 Review. No abstract available.
Cited by
-
[18F]FEPPA PET imaging for monitoring CD68-positive microglia/macrophage neuroinflammation in nonhuman primates.EJNMMI Res. 2020 Aug 6;10(1):93. doi: 10.1186/s13550-020-00683-5. EJNMMI Res. 2020. PMID: 32761399 Free PMC article.
-
Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach.Am J Nucl Med Mol Imaging. 2016 Sep 22;6(5):234-261. eCollection 2016. Am J Nucl Med Mol Imaging. 2016. PMID: 27766183 Free PMC article. Review.
-
Effects of Sertoli cell-conditioned medium on ventral midbrain neural stem cells: a preliminary report.Neurotox Res. 2008 May-Jun;13(3-4):241-6. doi: 10.1007/BF03033507. Neurotox Res. 2008. PMID: 18522903
-
Specification and differentiation of serotonergic neurons.Stem Cell Rev. 2006;2(1):5-10. doi: 10.1007/s12015-006-0002-2. Stem Cell Rev. 2006. PMID: 17142880 Review.
-
Changes in the content of estrogen alpha and progesterone receptors during differentiation of mouse embryonic stem cells to dopamine neurons.Brain Res Bull. 2007 Jun 15;73(1-3):75-80. doi: 10.1016/j.brainresbull.2007.02.002. Epub 2007 Feb 28. Brain Res Bull. 2007. PMID: 17499639 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
